Literature DB >> 8443483

Haemolytic uraemic syndrome during treatment with ketorolac trometamol.

M L Randi1, T Tison, G Luzzatto, A Girolami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8443483      PMCID： PMC1676573          DOI： 10.1136/bmj.306.6871.186-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Ketorolac-induced acute renal failure.

Authors:  L A Boras-Uber; N C Brackett
Journal:  Am J Med       Date:  1992-04       Impact factor: 4.965

Review 2.  The clinical significance of inhibition of renal prostaglandin synthesis.

Authors:  C Patrono; M J Dunn
Journal:  Kidney Int       Date:  1987-07       Impact factor: 10.612

Review 3.  Effects of non-narcotic analgesics on the kidney.

Authors:  P Kincaid-Smith
Journal:  Drugs       Date:  1986       Impact factor: 9.546
  3 in total
  2 in total

Review 1.  Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.

Authors:  J C Gillis; R N Brogden
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

2.  A matched case-control study to assess the association between non-steroidal anti-inflammatory drug use and thrombotic microangiopathy.

Authors:  Aiden R Liu; Ainslie M Hildebrand; Stephanie Dixon; Jessica M Sontrop; William F Clark; Alejandro Lazo-Langner; Danielle Nash; Amit X Garg
Journal:  PLoS One       Date:  2018-08-24       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.